By continuing to use our site, you are agreeing for us to set a small number of cookies. Cookie policy


Use of antipsychotic medication in care homes

Response to the consultation

Evidence submitted in response to this Consultation

Purpose of the consultation

The Health, Social Care and Sport Committee welcomed your views on the terms of reference for the inquiry.


Terms of reference

The use of antipsychotic medication in care home settings, and the ways in which its inappropriate use could be reduced, including the consideration of:

  • the availability of data on the prescribing of antipsychotics in care homes, to understand prevalence and patterns of use;
  • prescribing practices, including implementation of clinical guidance and medication reviews;  
  • provision of alternative (non-pharmacological) treatment options;
  • training for health and care staff to support the provision of person-centred care for care home residents living with dementia;
  • identifying best practice, and the effectiveness of initiatives introduced so far to reduce inappropriate prescribing of antipsychotics;
  • use of antipsychotic medication for people with dementia in other types of care settings.



Submissions should be no longer than five sides of A4, with numbered paragraphs, and should focus on matters set out above. Please see guidance for those providing evidence for committees.


The deadline for responses was 21 April 2017. Please send your views to:


Bilingual Policy

The Committee welcomes contributions in English or Welsh, and we ask organisations with Welsh Language policies/schemes to provide bilingual responses, where applicable, in line with their public information policies.


Disclosure of Information

You can find further details about how we will use your information at Please ensure that you have considered these details carefully before submitting information to the Committee.



You are in :

  1. Home
  2. Assembly Business

Partners & Help